Breaking News:

Article ID: 713132

Scientists from the University of Adelaide’s Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world’s most deadly respiratory diseases.

Article ID: 712764

Research uncovers key mechanism that allows some of the deadliest human RNA viruses to orchestrate the precise copying of the individual pieces of their viral genome and replicate. Research reveals that the tail end of a virus’s RNA plays a key role in ensuring each segment of the viral genome is copied in the correct amount. Experiments show the viral replication machinery latches onto the 5' end of the virus’s RNA strand, a move that activates the enzyme to start copying at the opposite end of a specific segment. The findings identify new targets to inhibit viral replication and may inform the development of a novel class of antiviral drugs.

Article ID: 712549

Highest honor recognizing outstanding contributions to science

Article ID: 712292

Funds from the National Institutes of Health will accelerate the chase for one of medicine’s most elusive goals: a universal influenza vaccine.

Article ID: 711846

A new technology developed by the University of Wisconsin–Madison’s Yoshihiro Kawaoka may make H3N2 vaccine development a bit easier. In Nature Microbiology today [April 29, 2019], Kawaoka and his team describe a new cell line that enables better growth of H3N2 for vaccine use. The virus is also far less likely to mutate during production using this cell line, improving the chances of a match between vaccine and circulating influenza viruses.

Article ID: 711830

Folk medicines and herbal products have been used for millennia to combat a whole range of ailments, at times to the chagrin of modern scientists who have struggled to explain their medicinal benefits.

Article ID: 710400

Research conducted in mice suggests the food additive tert-butylhydroquinone (tBHQ)—found in many common products from frozen meat to crackers and fried foods—suppresses the immune response the body mounts when fighting the flu.

Article ID: 710684

Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.

Article ID: 709731

Article ID: 709582

When flu season peaks after mid-winter, tens of thousands of influenza cases and hundreds of deaths can likely be avoided if older adults wait until October to get their flu immunization, a University of Pittsburgh School of Medicine analysis reveals.